For open access publishing IJLR uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and IJLR will be granted publishing and distribution rights.
In particular, copyright (rights in editorial content), trademarks (rights in brands for services or journals), and database rights (rights in compilations of information), form the IJLR. IJLR embraces the opportunities the digital environment offers for communication and access, while at the same time recognizing the new risks that this environment poses: the ease with which unauthorized copies can be made and distributed worldwide.
Our Objective We aim to manage digital rights and brands amidst the structural changes that the “information society” represents, while at the same time recognizing the shared goals we have with our customers and authors. These include providing the widest possible distribution of scientific and medical content and services in a financially sustainable business model. IJLR wants to ensure a proper balance between the scholarly rights which authors retain (or are granted/transferred back in some cases) and the rights granted to IJLR that are necessary to support our mix of business models. We routinely analyze and modify our policies to ensure we are responding to authors’ needs and concerns, and the concerns generally of the research and scholarly communities. Disclosure Statement for Authors At the end of the text, under a subheading “Disclosure Statement”, all authors must disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three (3) years of beginning the work submitted that could inappropriately influence (bias) their work. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest possible stage.